AN ONCOLOGY-DEDICATED DRUG DEVELOPMENT COMPANY
Thank you for subscribing!
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.
Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)
Ascelia Pharma company presentation Oct 2021 (pdf)
Q2 2021 presentation (pdf), link to webcast